The program will focus on a multidisciplinary quality team designated as the C. diff Infection Reduction Team initiated at Huntsville (Ala.) Hospital. The purpose of the team is to implement strategies to reduce the occurrence of C. diff.
The presenter, Edward Eiland, PharmD, MBA, BCPS (AQ-ID), clinical practice and business supervisor in the department of pharmacy at Huntsville Hospital System, will review Huntsville Hospital’s implementation of a pathway that addresses microbiology lab diagnostics, isolation procedures, treatment recommendations and monitoring parameters, according to the release.
The webinar takes place Oct. 26 from 2:00 p.m.- 3:00 p.m. ET.
To learn more about the program and register, click here.
Related Articles on Clostridium Difficile:
Patient Safety Tool: Clostridium Difficile Environmental Cleaning Checklist
Central New York Hospitals Fight to Control C. Difficile
12 CDC Recommendations to Prevent Clostridium Difficile Infections
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.